Senior insider sale
EVP, Head of International at RHYTHM PHARMACEUTICALS, INC. — senior position signals high conviction
$6.43M
57K shares
What this filing means
MAZABRAUD YANN plans to sell 57K shares of RHYTHM PHARMACEUTICALS, INC. valued at approximately $6.43M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/12/2026ACC: 0001950047-26-008030
Officer· EVP, Head of International
Since Oct 2020
57K
Shares to sell
$6.43M
Approx. market value
57K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
8/12/2026
46.63KRestricted Stock Units
N/A
4/14/2024
10.38KTotal acquired57K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/12/2026 | Exercise of Stock Options Cash | 46.63K | — |
4/14/2024 | Restricted Stock Units N/A | 10.38K | — |
| Total | 57K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
57K
Market value
$6.43M
8/12/2026
Total
Units
57K
Value
$6.43M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/12/2026 | 57K | $6.43M | NASDAQ | Planned |
| Total | 57K | $6.43M | ||